The use of immune effector cell therapies can result in significant toxicities that are directly associated with powerful immune-mediated responses. The most frequently observed of these is cytokine release syndrome (CRS). CRS represents a life-threatening situation that requires early recognition of symptoms and signs and prompt intervention. This short training video can be used to support healthcare professionals and others to gain an introduction to CRS presentation, diagnosis and clinical management.
Training video: management of Cytokine Release Syndrome in patients receiving CAR T cell therapy
Kamilah Lakhani-Powell2021-10-06T09:45:34+01:006th October 2021|